SPDL1 and cholangiocarcinoma: SPDL1 was upregulated in bladder cancer, breast cancer, cholangiocarcinoma, ESCA, squamous cell cancer in the head and neck region, kidney renal clear cell carcinoma, and other tissues, but was downregulated in kidney chromophobe tissues (Supplementary Figure S1).